American Well Corporation — Cyborg Score 4/10

Mixed
Digital health platforms and telehealth infrastructure

Strategic Profile

Amwell entered 2026 focused on consolidating its platform to fulfill unmet customer needs, with its Technology-Enabled Care infrastructure gaining traction by delivering lower costs, better outcomes, stronger market share, and increased control for customers. The company has ample cash, no debt, and a clear path to cash flow breakeven in Q4 2026 with confidence in multiyear growth beyond it.

Cyborg Score Rationale

Amwell delivered strong Q1 2026 results with revenue of $54.9M, outperformance driven by strong visit volumes and cost discipline, demonstrating continued progress toward profitability. However, the business remains meaningfully loss-making and dependent on continued discipline.

Top Insights

  • Full-year 2026 guidance of $195-205M revenue (down from 2025's $249M) targets profitability with adjusted EBITDA loss narrowing to $16-12M.
  • Key customer wins include Elevance's 3-year renewal and DHA's global deployment, demonstrating platform validation.
  • The platform is built to leverage AI-powered innovations, positioning it as essential infrastructure for tech-enabled care delivery.
  • CMS increasingly making telehealth flexibilities permanent, creating tailwinds for the telehealth market.

Named Competitors

  • Teladoc Health — Virtual care and telehealth platform
  • Sharecare — Digital health engagement platform
  • Accolade — Health benefits navigation and advocacy
  • Talkspace — Online mental health and therapy platform
  • InTouch Health — Remote patient monitoring and telehealth solutions

Recent Developments

  • (May 2026) Amwell announced Q1 2026 earnings with $54.9M revenue, improved margins, and reaffirmed path to Q4 2026 cash flow breakeven.
  • (May 2026) SilverCloud by Amwell published Nature Human Behaviour study showing reduction in mental disorder prevalence over two years.
  • (February 2026) Announced full-year 2025 results with net loss improved to $95.0M from $212.6M and adjusted EBITDA loss narrowing to $(39.9)M from $(134.4)M.
  • (Early 2026) Divested APC business and consolidated platform focus on Technology-Enabled Care.

Open the full interactive American Well Corporation report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →